Through
4/26
A senior in the course Health and the Health Care System in Chile reflects on lessons from a 10-day Nursing Study Abroad winter break trip, which offered a holistic view of the South American country’s health system.
The research, from Penn Nursing and Annenberg, points to a need to change the feedback loop on these channels and to dispel myths about what constitutes normal behaviors.
In a Q&A, PIK Professor Jonathan Moreno discusses using CRISPR technology on humans and the future of the field.
Next week’s midterm elections will affect health-related issues. Three Penn experts weigh in with their opinions on how the results may change health care in general, women’s health, and environmental policy.
The two schools are joining forces to launch an executive health care leadership program, Leadership in a New Era of Health Care, for senior-level leaders in health care and academic medicine.
The two-year effort includes electronic research notebooks, a research symposium, and a task force of faculty and students, all spearheaded by the Office of the Vice Provost for Research.
In the United States, the majority of women have to work. But of the 151 largest U.S. cities, only New York and Philadelphia safeguard their rights.
Foreign aid makes up close to half of Mozambique’s national health care budget. In a new book, Ramah McKay of the School of Arts and Science lends a critical eye toward how this influx of global health dollars is felt on the ground, by caregivers and patients alike.
When St. Joseph Aspirin for Children was introduced in the 1940s, it was formulated to be attractive in taste and color to its young audience. Dubbed “candy aspirin,” the product became popular—fast. As a consequence, aspirin poisonings of children under five skyrocketed.
The School of Arts and Sciences’ Charles Yang and Charles L. Bosk, also of the Perelman School of Medicine, have been named Guggenheim Fellows.
PIK Professor Ezekiel Emanuel says that incessantly preparing for old age mistakes a long life for a worthwhile one.
FULL STORY →
PIK Professor Ezekiel Emanuel says that there should be definitive benefits to cancer drugs five years after their initial accelerated approval.
FULL STORY →
Experts on a panel at the Leonard Davis Institute last year said that private equity-backed health care businesses should not have special rules for issues like reimbursement and transparency.
FULL STORY →
Holly Fernandez Lynch of the Perelman School of Medicine says that the lack of good treatment options for ALS has led to an insatiable desire to develop something that is going to modify the course of this disease.
FULL STORY →
Rachel M. Werner of the Leonard Davis Institute, Wharton School, and Perelman School of Medicine says that the U.S. lacks any sort of comprehensive approach to funding for long-term care.
FULL STORY →
Karen Lasater of the School of Nursing and Leonard Davis Institute says that the nursing shortage crisis is rooted in unsafe staffing ratios at hospitals.
FULL STORY →